SL THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,384 KRW | +9.75% |
|
-22.42% | +134.97% |
| 2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
| 2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 47.6L | - | - | - | - | - | |
| 9.45TCr | ||||||
| 3.89TCr | ||||||
| 3.26TCr | ||||||
| 1.6TCr | ||||||
| 1.38TCr |
